Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial

Thierry Conroy, Florence Castan, Pierre-Luc Etienne, E. Rio, Nathalie Mesgouez‐Nebout, Ludovic Evesque, V. Vendrely, Xavier Artignan, Olivier Bouché, D. Gargot, Valérie Boige, Nathalie Bonichon-Lamichhane, Christophe Louvet, Clotilde Morand, Christelle de la Fouchardière, Alice Boilève, Matthieu Delaye, Sophie Gourgou, Veronica Pezzella, Christophe Borg